Estée Lauder

Ticker: EL US

Sector: Beauty

Rating: Buy

Published Research

Estée Lauder: Capitulation at Last after Q1 FY25 Results? (November 2024)

Estée Lauder: Turnaround Progressing in Q4 FY24, with Baby Steps (August 2024)

Estée Lauder: Market Ignores Return to Growth in Q3 FY24 (May 2024)

Estée Lauder: Inflection Point After Q2 FY24 (February 2024)

Estée Lauder: Recovery Again Postponed; Back to 2017 Levels, Unfairly (November 2023)

Estée Lauder: Near COVID-19 Low After Q4 FY23 Results (August 2023)

Estée Lauder: Shares Fell 17% as Q3 FY23 Revealed Past Mistakes (May 2023)

Legacy Seeking Alpha Articles

Estée Lauder: Down 11% In A Month Since Q2 FY23 Results (March 2023)

Estée Lauder: Poor Q1 FY23 Results, Much Worse Than Peers (November 2022)

Estée Lauder: COVID In China Drove Weak Q4 Results & FY23 Outlook (August 2022)

Estée Lauder: Temporary China Disruption Since Q3 FY22 (May 2022)

Estée Lauder: Beauty Stock On Sale After 26% Fall Since January (March 2022)

Estée Lauder: Double-Digit Sales Rebound In Q1, More To Come In FY (November 2021)

Estée Lauder: Strong FY21 Finish; Double-Digit Growth Resuming (August 2021)

Estée Lauder: COVID To Blame For Weak Q3 FY21 And 8% Correction (May 2021)

Estée Lauder: Earnings Already Surpassed Pre-COVID Level, More To Come (March 2021)

Estée Lauder: Multiple Engines Powering Sequential Recovery Each Quarter (November 2020)

Estée Lauder: Positive Signs For Return Of Double-Digit EPS Growth (August 2020)

Beauty In COVID-19: Assessing Q1 And Reiterating Buy (May 2020)

Estée Lauder: 26% Off Peak After COVID-19 Is An Opportunity (Initiation) (April 2020)